Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leland Metheny, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Kansas Cancer Center
Westwood, Kansas, United States
Recruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - University of Nebraska Medical Center
Omaha, Nebraska, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Active, not recruiting - Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Active, not recruiting - University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Leland MethenyRecruiting - the James Cancer Hospital and Solove Research Institute
Columbus, Ohio, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2017
- Primary completion
- 30 Nov 2025
- Completion
- 31 May 2027
- Last update posted
- 5 Jun 2025
- Registered enrollment
- 44
- Registry id
- NCT03104491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.